实验性瘤-浸润淋巴细胞治疗晚期癌--深度搜 UN:GWQB.0.1987-01-001 [摘要] 正 用白细胞间素-2(IL-2)扩增的瘤-浸润淋巴细胞(tumor-infiltrating lym-phocytes,TIL)治疗小鼠各种肿瘤的微小转移,其效力是用淋巴因子激活的杀伤(LAK)细胞治疗的50～100倍。因此,进
基于1个网页-相关网页
肿瘤浸润淋巴细胞 TIL ; tumor infiltrating lymphocyte ; tumor-infiltrating lymphocyteTIL ; tumor infiltrating cells
瘤浸润淋巴细胞 tumor infiltrating lymphocyte ; TIL ; tumor infiltrating cells
肿瘤浸润性淋巴细胞 tumor infiltrating lymphocytes ; TIL ; tumor-infiltration lymphocyte ; Tumor-infiltrating lymphocytes
③肿瘤浸润淋巴细胞 tumor infiltrating lymphocyte
阳性肿瘤浸润淋巴细胞 tumor-infiltration lymphocyte ; TIL
的肿瘤浸润淋巴细胞 tumor infiltrating lymphocytes
⑶肿瘤浸润淋巴细胞 tumor infiltrating lymphocyte
癌肿瘤浸润淋巴细胞 tumor-infiltration lymphocyte
和肿瘤浸润淋巴细胞 tumor infiItrating lymphocyte
结果：HE中瘤细胞呈梭形、不规则形，排列无序，间杂以淋巴细胞等浸润及胶原纤维束；
Results In HE staining, the tumor cell was spindle, irregular and disorder arrangement, mixing with lymph cell and collagen fibers.
结果NK/T淋巴瘤组织结构特点为多形性淋巴细胞增生，大片的凝固性坏死和血管浸润，免疫组化表达CD3、CD45和CD56阳性。
Results Proliferation of pleomorphic lymphocyte, coagulation necrosis of massive tissue and vaso-infiltration were showed in the NK/T lymphoma; tumor cells were positive for CD3, CD45 and CD56.
瘤体中有大量炎性细胞浸润，以淋巴细胞和中性粒细胞为主。
A number of infiltrating inflammatory cells such as lymphocytes and neutrophils could be observed in the treated tumor mass.
应用推荐